Was antithymocyte globulin the cause of hemolytic uremic syndrome?
Proesmans
W
W
University Hospital Gasthuisberg, Leuven, Belgium.
D000961:Antilymphocyte Serum / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D012008:Recurrence
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents